The efficacy of Virtual Reality in Burn Care Psychological variables associated with the effect of VR during wound care

The efficacy of Virtual Reality in Burn Care Psychological variables associated with the effect of VR during wound care - The efficacy of Virtual Reality in Burn Care

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42779

Enrollment

128

Registered

2015-12-30

Start date

2016-10-03

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brandwonden Pain Satisfaction

Interventions

None listed

Eligibility

Age

2 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age 8 years and older - Expected admission time for at least 4 days - Informed consent - Mentally competent - Dutch speaking and reading - Permission of doctor - Permission of psychiatrist - Ability to use VR

Exclusion criteria

Exclusion criteria: - Physical impairments (facial burns) - Need for intensive care / severe comorbidity

Design outcomes

Primary

Measure	Time frame
VR is effective in reducing pain, when there are both statistically and clinically significant differences between the VAS-scores of overall pain during care as usual with VR and care as usual. The clinically significant difference include that the VAS-score of overall pain during care as usual with VR is *0.9 cm lower than the VAS-score of overall pain during care as usual	—

Secondary

Measure	Time frame
- The satisfaction with the use of VR is meaningful when the VAS-score of satisfaction with care as usual with VR is not statistically and clinically significantly lower than the VAS-score of satisfaction with care as usual. The clinically significant difference include that the VAS-score of satisfaction with care as usual with VR is not *0.9 cm lower than the VAS-score of satisfaction with care as usual. - The identification of independent variables associated with the expected statistically and clinically significant differences in pain and satisfaction, between care as usual with VR and care as usual. - The number of milligrams sedation and/or analgesics used during care as usual with VR compared to care as usual. - The number of minutes of care as usual with VR compared to care as usual. - The number of patients reporting nausea as a consequence of the use of VR. - The description of the user friendliness of the VR-equipment with patients and medical professionals.	—

Measure

Time frame

- The satisfaction with the use of VR is meaningful when the VAS-score of satisfaction with care as usual with VR is not statistically and clinically significantly lower than the VAS-score of satisfaction with care as usual. The clinically significant difference include that the VAS-score of satisfaction with care as usual with VR is not *0.9 cm lower than the VAS-score of satisfaction with care as usual. - The identification of independent variables associated with the expected statistically and clinically significant differences in pain and satisfaction, between care as usual with VR and care as usual. - The number of milligrams sedation and/or analgesics used during care as usual with VR compared to care as usual. - The number of minutes of care as usual with VR compared to care as usual. - The number of patients reporting nausea as a consequence of the use of VR. - The description of the user friendliness of the VR-equipment with patients and medical professionals.

—

Countries

Netherlands

Outcome results